Complement 1 provides personalized lifestyle medicine programs for cancer patients, integrating evidence-based nutrition, exercise, and stress management to improve treatment outcomes and quality of life. Their platform delivers tailored interventions and support, empowering patients to actively participate in their recovery journey.
Funding
$16M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.


Founders
Product
Problem
Cancer patients often experience debilitating complications that require customized care, yet less than 5% adhere to recommended lifestyle interventions like physical activity and nutrition, leading to increased recurrence and mortality rates. Existing wellness programs often lack the necessary frequency and personalization to drive measurable outcomes and sustained behavior change.
Solution
Complement 1 delivers personalized lifestyle medicine programs for cancer patients and high-risk individuals, integrating evidence-based nutrition, exercise, and stress management through daily, one-on-one coaching. The platform provides customized plans tailored to cancer treatment, type, and stage, adapting to the patient's condition each day. Progress is tracked and shared with care teams, ensuring alignment with clinical goals. By offering daily live sessions, Complement 1 aims to improve adherence, enhance quality of life, and reduce cancer-related costs.
Target Audience
The primary target audience includes cancer patients, survivors, individuals at high risk of cancer, health plans, healthcare providers, and employers seeking to improve cancer-related health outcomes and reduce costs.
Features
- Daily 1:1 live intervention with a CoActive Coach, including exercise, nutrition, and breathwork.
- Personalized plans customized for cancer treatment, type, and stage.
- Integration with care teams to ensure progress aligns with clinical goals.
- Trauma-informed coaching, cancer exercise, and cancer nutrition guidance.
- Validated by IRB clinical RCT, demonstrating improved health outcomes.